1. Cui, Yan-Hong, Kim, Hyeonmi, Lee, Minyoung, Kaushik, Neha, Lee, Su-Jae. 2018. FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation. In Oncogene, 37, 5794-5809. doi:10.1038/s41388-018-0372-3. https://pubmed.ncbi.nlm.nih.gov/29973690/
2. Gao, Enyi, Sun, Xiaoya, Thorne, Rick Francis, Ma, Jianli, Wu, Mian. 2023. NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells. In Journal of translational medicine, 21, 401. doi:10.1186/s12967-023-04232-1. https://pubmed.ncbi.nlm.nih.gov/37340421/
3. Zhou, Qingxin, Lin, Meihua, Feng, Xing, Zou, Chang, Zhang, Zhiyong. . Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. In The Journal of experimental medicine, 217, . doi:10.1084/jem.20191779. https://pubmed.ncbi.nlm.nih.gov/32453420/
4. Chen, Fangfang, Zhang, Chunxiao, Wu, Haonan, Zhang, Hui, Lu, Fei. 2017. The E3 ubiquitin ligase SCFFBXL14 complex stimulates neuronal differentiation by targeting the Notch signaling factor HES1 for proteolysis. In The Journal of biological chemistry, 292, 20100-20112. doi:10.1074/jbc.M117.815001. https://pubmed.ncbi.nlm.nih.gov/29070679/
5. Zhang, Tao, Jiang, Weidong, Liao, Fengchun, Huang, Xuanping, Zhou, Nuo. 2022. Identification of the key exosomal lncRNAs/mRNAs in the serum during distraction osteogenesis. In Journal of orthopaedic surgery and research, 17, 291. doi:10.1186/s13018-022-03163-9. https://pubmed.ncbi.nlm.nih.gov/35643547/
智鼠故事 
